2023 European Society of Cardiology guidelines on the management of cardiomyopathies

Fig. 1. Update of the cardiomyopathy classification system to include uniform, describing diagnoses which lead to a conceptual framework for diagnosis and treatment [1] (HCM hypertrophic cardiomyopathy, DCM dilated cardiomyopathy, NDLVC non-dilated left ventricular cardiomyopathy, ARVC arrhythmogenic right ventricular cardiomyopathy, RCM restrictive cardiomyopathy, SCD sudden cardiac death, ICD implantable cardioverter-defibrillator, LVOTO left ventricular outflow tract obstruction, GDMT guideline-directed medical therapy, HF heart failure, PVR pulmonary vascular resistance). (Reproduced with the permission of Oxford University Press)

Fig. 2. Integration of cardiogenetics into clinical cardiology practice requires expertise from different specialties, resulting in a multidisciplinary expertise team [1]. (Reproduced with the permission of Oxford University Press)

Fig. 3. Schematic representation of local/regional, national and international shared-care expertise networks for Dutch cardiogenetics practice (NVVC Netherlands Society of Cardiology (Nederlandse Vereniging voor Cardiologie), NFU Netherlands Federation of University Medical Centres (Nederlandse Federatie Universitair Medische Centra))